Published date: 12 September 2024
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£230,000,000
Procurement reference
CF-2562800D0O000000rwimUAA
Published date
12 September 2024
Closing date
1 July 2024
Closing time
1pm
Contract start date
1 September 2024
Contract end date
31 August 2026
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024
Offer reference number: CM/TNS/24/5711
CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
More information
Attachments
-
- 2024S 000-017062 - FTS Opportunity Notice - NHS National Framework for the supply of Ustekinumab CM-TNS-24-5711.pdf
- 2024S 000-017062 - FTS Opportunity Notice - NHS National Framework for the supply of Ustekinumab CM-TNS-24-5711
-
- Document No. 10 - Participating Authorities - CM_TNS_24_5711.xls
- Document No. 10 - Participating Authorities - CM_TNS_24_5711
-
- Document No. 03 - Framework Agreement and Terms and Conditions - CM_TNS_24_5711.docx
- Document No. 03 - Framework Agreement and Terms and Conditions - CM_TNS_24_5711
-
- Transparency Award Documents - CM-TNS-24-5711 Lots 1 and 2.pdf
- Transparency Award Documents - CM-TNS-24-5711 Lots 1 and 2
-
- Parties Appointed to the Framework Agreement - CM-TNS-24-5711.docx
- Parties Appointed to the Framework Agreement - CM-TNS-24-5711
Award information
Awarded date
13 August 2024
Contract start date
1 September 2024
Contract end date
31 August 2026
Total value of contract
£230,000,000
This contract was awarded to 6 suppliers.
Amgen Ltd
Address
216 Science Park Milton Road, Cambridge, CB4 0WA
Reference
None
Supplier is SME?
No
Sandoz Ltd
Address
Park View, Riverside Way, Watchmoor Park,, Camberley, Surrey., GU15 3YL
Reference
None
Supplier is SME?
Yes
Thornton and Ross Ltd
Address
Linthwaite Laboratories, Manchester Road, Linthwaite,, Huddersfield, HD7 5QH
Reference
None
Supplier is SME?
No
Celltrion Healthcare United Kingdom Limited
Address
The Switch ,1-7 The Grove,, Slough, SL1 1QP
Reference
None
Supplier is SME?
No
Janssen-Cilag Ltd
Address
50-100 Holmers Farm Way,, HighWycombe,, HP12 4EG
Reference
None
Supplier is SME?
No
Accord-UK Ltd
Address
Whiddon Valley,, Barnstaple, Devon,, EX32 8NS
Reference
None
Supplier is SME?
No
About the buyer
Contact name
Katie Noonan
Address
Rutland House
Runcorn
WA7 2ES
GB
Share this notice
Closing: 1 July 2024, 1pm